Eastman Chemical Stock To Go Ex-dividend Tomorrow (EMN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for Eastman Chemical Company (NYSE: EMN) is tomorrow, June 12, 2013. Owners of shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $69.42 as of 9:30 a.m. ET, the dividend yield is 1.7%.

The average volume for Eastman Chemical has been 1.7 million shares per day over the past 30 days. Eastman Chemical has a market cap of $10.9 billion and is part of the basic materials sector and chemicals industry. Shares are up 3.7% year to date as of the close of trading on Monday.

Eastman Chemical Company, a specialty chemical company, engages in the manufacture and sale of chemicals, plastics, and fibers in the United States and internationally. The company has a P/E ratio of 21, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Eastman Chemical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels, solid stock price performance, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Eastman Chemical Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids

Are Trump Stocks a Crowded Trade?

Avangrid Chart Shows Good Fundamentals Not Everything in Trading

Here's Why These 3 Stocks With Alluring Dividends Are Strong Buys

Bullish and Bearish Reversals for the Week